Share to: share facebook share twitter share wa share telegram print page

Methoxamine

Not to be confused with methoxetamine.
Methoxamine
Clinical data
Trade namesVasoxine, Vasoxyl, Vasylox, others
Other namesMethoxamedrine; 2,6-Dimethoxy-β-hydroxy-α-methylphenethylamine; 2,6-Dimethoxy-β-hydroxyamphetamine
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Oral, injection[1]
ATC code
Pharmacokinetic data
Elimination half-life3 hours
ExcretionUrine
Identifiers
  • 2-amino-1-(2,5-dimethoxyphenyl)propan-1-ol
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.006.244 Edit this at Wikidata
Chemical and physical data
FormulaC11H17NO3
Molar mass211.261 g·mol−1
3D model (JSmol)
  • O(c1ccc(OC)cc1C(O)C(N)C)C
  • InChI=1S/C11H17NO3/c1-7(12)11(13)9-6-8(14-2)4-5-10(9)15-3/h4-7,11,13H,12H2,1-3H3 checkY
  • Key:WJAJPNHVVFWKKL-UHFFFAOYSA-N checkY
  (verify)

Methoxamine, sold under the brand names Vasoxine, Vasoxyl, and Vasylox among others, is a sympathomimetic medication used as an antihypotensive agent.[2][3][4][5] It has mostly or entirely been discontinued.[6]

The drug is an α1-adrenergic receptor agonist.[4][additional citation(s) needed]

Medical uses

The long duration of action of methoxamine has been said to have rendered it obsolete in modern clinical practice.[2]

Pharmacology

Methoxamine is an α1-adrenergic receptor agonist.[2] It is described as a long-acting α1-adrenergic receptor agonist and this is contrasted with phenylephrine which is said to be short-acting.[2] Phenylephrine is 5 to 10 times more potent than methoxamine and has a 3-fold higher maximal effect.[2]

Chemistry

Methoxamine, also known as 2,6-dimethoxy-β-hydroxy-α-methylphenethylamine or as 2,6-dimethoxy-β-hydroxyamphetamine, is a substituted phenethylamine and amphetamine derivative.[3]

It is somewhat similar in chemical structure to those of desglymidodrine (3,6-dimethoxy-β-hydroxyphenethylamine), dimetofrine (3,5-dimethoxy-4,β-dihydroxy-N-methylphenethylamine), 2,5-dimethoxyamphetamine (2,5-DMA), and butaxamine ((1S,2S)-3,6-dimethoxy-β-hydroxy-N-tert-butylamphetamine).

History

Methoxamine was synthesized by 1944.[3] It was marketed in the United States by 1949.[1]

Society and culture

Names

Methoxamine is the generic name of the drug and its INNTooltip International Nonproprietary Name and BANTooltip British Approved Name, while méthoxamine is its DCFTooltip Dénomination Commune Française and methoxamina is its DCITTooltip Denominazione Comune Italiana.[3][4][6] In the case of the hydrochloride salt, its generic name is methoxamine hydrochloride and this is its USANTooltip United States Adopted Name, BANMTooltip British Approved Name, and JANTooltip Japanese Accepted Name.[3][4][7][6] A synonym of methoxamine is methoxamedrine.[4] The drug has been sold under brand names including Idasal, Mexan, Pressomin, Vasosterol, Vasoxine, Vasoxyl, and Vasylox.[3][4][6]

Availability

Methoxamine has been marketed in Canada, the Czech Republic, Ireland, Japan, Spain, the United Kingdom, and the United States and was available in these countries in 2000.[4][6] However, it was discontinued in Canada and the United Kingdom by 2004.[7] It has also been discontinued in the United States.[1] By 2016, methoxamine appeared to remain available only in Japan.[6]

References

  1. ^ a b c "Drugs@FDA: FDA-Approved Drugs". accessdata.fda.gov. Retrieved 1 September 2024.
  2. ^ a b c d e Thiele RH, Nemergut EC, Lynch C (August 2011). "The physiologic implications of isolated alpha(1) adrenergic stimulation". Anesth Analg. 113 (2): 284–296. doi:10.1213/ANE.0b013e3182124c0e. PMID 21519050.
  3. ^ a b c d e f Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 788. ISBN 978-1-4757-2085-3. Retrieved 2024-09-01.
  4. ^ a b c d e f g Schweizerischer Apotheker-Verein (2000). Index Nominum 2000: International Drug Directory. Medpharm Scientific Publishers. p. 669. ISBN 978-3-88763-075-1. Retrieved 2024-09-01.
  5. ^ Pazdernik TL, Kerecsen L (2007) [2003]. "5". In Goljan EF (ed.). Pharmacology. Rapid Review (Second ed.). Philadelphia, PA: Mosby-Elsevier. p. 39. ISBN 978-0-323-04550-6.
  6. ^ a b c d e f "Methoxamine". 20 October 2012. Archived from the original on 3 March 2016. Retrieved 1 September 2024.{{cite web}}: CS1 maint: unfit URL (link)
  7. ^ a b Schweizerischer Apotheker-Verein (2004). Index Nominum: International Drug Directory. Medpharm Scientific Publishers. p. 779. ISBN 978-3-88763-101-7. Retrieved 1 September 2024.
Kembali kehalaman sebelumnya